PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2023-02-08

Date Title Company
08-Feb-2023 EnPlusOne Biosciences Expands Scientific Advisory Board Businesswire
08-Feb-2023 Bayer Aktiengesellschaft: William N. Anderson to succeed Werner Baumann as Chairman of the Board of Management of Bayer AG Bayer Aktiengesellschaft
08-Feb-2023 Doreen Devine Joins Alliant Insurance Services’ New York Team Businesswire
08-Feb-2023 Canada's Biotech Sector Gets Boost with New Compensation Guide Businesswire
08-Feb-2023 Astria Therapeutics Initiates ALPHA-STAR Phase 1b/2 Clinical Trial of STAR-0215 in People with HAE Businesswire
08-Feb-2023 Lineage Provides Update on Auditory Neuronal Cell Transplant Program for the Treatment of Hearing Loss Businesswire
08-Feb-2023 AmerisourceBergen Releases 2022 ESG Summary Report to Share Progress and Impact on Environmental, Social and Governance Priorities Businesswire
08-Feb-2023 Strateos Appoints Alexander K. Arrow as Chief Financial Officer and Expands Team Businesswire
08-Feb-2023 Thermo Fisher Scientific Launches TrueMark STI Select Panel Businesswire
08-Feb-2023 AdaCore Joins Rust Foundation as Silver Member Businesswire
08-Feb-2023 Availability of Sanofi’s Nexviadyme®▼(avalglucosidase alfa) provides NHS with new treatment for Pompe disease Sanofi
08-Feb-2023 Bionik Laboratories Reports Third Quarter Fiscal Year 2023 Financial Results Businesswire
08-Feb-2023 Andersen’s Aggressive Growth Moves Stateside: Expands Presence in Orange County, Adds New Offices in Des Moines and Pittsburgh Businesswire
08-Feb-2023 Appili Therapeutics Announces that FDA accepts the ATI-1501 NDA Businesswire
08-Feb-2023 Sartorius Stedim Biotech SA: Board of Directors of Sartorius Stedim Biotech resolves to propose a dividend of 1.44 euros per share to the Annual Shareholders’ Meeting Sartorius Stedim Biotech SA
08-Feb-2023 Bicycle Therapeutics to Participate in the SVB Securities Global Biopharma Conference Businesswire
08-Feb-2023 Silence Therapeutics to Present at SVB Securities Global Biopharma Conference Businesswire
08-Feb-2023 Teva Reports Fourth Quarter and Full Year 2022 Financial Results Businesswire
08-Feb-2023 The new DUSA Shaker™ DTS 100i from Copley: For faster, safer, more repeatable inhaler testing Copley Scientific
08-Feb-2023 BioSenic announces the approval and publication of the Prospectus for listing and admission to trading of the shares and subscription rights issued in the context of the capital increase by way of in kind contributions of Medsenic 51 percent participation BioSenic